This Best Practices Report intends to bring our experience in European Industrial Doctorates (EID) to other consortia with awarded EID Programmes ongoing and to institutions considering applying for funding to this scheme.
The fellows will move to GSK's Tres Cantos site in Spain for the second stage of the project.
The fellows presented their first year scientific results at the GSK DDW site
The conference featured a discussion of target and compound discovery, new potential antituberculosis compounds which are in development, clinical trial design and early trial results, and alternative approaches to tuberculosis treatment.
Dr. David Barros, TB Drug Discovery Director at GSK DDW, was appointed Vice-chairman and Chairman for the 2013 and 2015 Conferences, respectively. More information on the Conference's website
left to right: Maciej Rogacki, Robert Bates, Eleni Pitta, Lluís Ballell, Pieter Van der Veken, Olga Balabon and David Barros